Learn how Kite’s industry-leading cell therapy technology harnesses the power of the immune system to target and attack tumors.
Goto again highlights the decisive steps that Astellas has taken in the cell therapy area. “A big factor in why Astellas has been able to lead a clinical trial in the field of ophthalmology is due to the acquisition of US biotechnology company Ocata Therapeutics in 2016. With Ocata within t...
Increased interest among Big Pharma in stem cell partnerships Expanding interest from investors in stem cell technologies Use of cell therapies in the treatment of pandemic related immune and respiratory complications Rising numbers of stem cell clinical trials worldwide Stem Cell Therapy Companies This ...
The translation of cell biology science to an applied medical therapy holds great allure for forward-thinkers in the medical industry. As with any other futuristic technologies, exotic therapies need to be more medically effective than current treatments, sufficiently robust to be scaled reproducibly, ...
#KOL on #Cell therapies: #CAR-T cells and #stem-cell-based approaches is moderator for Cell Therapy Landscape: Marcela Maus, MD, PhD Director, Cellular #Immunotherapy Program, #Cancer Center, MGH Associate Professor, Medicine, HMS @MGBInnovation @pharma_BI @AVIVA1950 #WMIF2022 Mass General ...
Adipose stem cell therapy - Anterogen Alternative Names: Allogeneic mesenchymal stem cells - Anterogen; Adipocell (Anterogen); AdipoPlus; Adipose-derived stem cells; ALLO-ASC; ALLO-ASC-DFU; ALLO-ASC-EB; ALLO-ASC-OA; ALLO-ASC-SHEET; ALLO-ASC-TI; Allogeneic adipose stem cells; ANTG-ASC; ...
Cell therapy is an innovative therapy that has emerged in recent years, but it has been subject to some awkward regulations in China. According to the National Health Commission (NHC), hospitals can legally use it as a medical technology in hospitals through admission approval. On the other han...
beating competitors from big pharma, in recognition of the cross-disciplinary nature of Solupore and its cutting-edge position in helping to usher in the next wave of cell-based, biologically engineered medicines. In addition to scientific accolades, Avectas recently received two votes of investor ...
Virtual R&D Day featuring partner Astellas Pharma and Poseida's leadership and scientific teams to be held today at10:00am ET/7:00am PT SAN DIEGO,Nov. 14, 2024/PRNewswire/ --Poseida Therapeutics, Inc.(Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company adva...
NKMAX said on Thursday that it has received FDA approval for its natural killer (NK) cell therapy SNK01 to treat Parkinson's disease under the Expanded Access Program (EAP).This makes NKMAX the first Korean biotech company to administer NK cell therapy t